HDAC1 and myeloproliferative disorder: MERCK60 is a preclinical HDACi with superior specificity for HDAC1 and HDAC2.24 In this work, we demonstrate that MERCK60 is significantly less toxic to normal human progenitor/stem cells than to MPN cells with highly active JAK2V617F-STAT signaling.